Regulation of Smad4 sumoylation and transforming growth factor-β signaling by protein inhibitor of activated STAT1

被引:69
作者
Liang, M
Melchior, F
Feng, XH
Lin, X
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
D O I
10.1074/jbc.M401554200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor, Smad4/DPC4, is a common signal transducer in transforming growth factor-beta (TGF-beta) signaling. In this study, we demonstrated that the protein inhibitor of activated STAT1 (PIAS1) regulates the signaling potential of Smad4 through a sumoylation-dependent mechanism. PIAS1 was shown to be an E3 ligase for Smad4 sumoylation in vitro and in vivo. PIAS1 physically interacted with Smad4 in a TGF-beta-inducible manner. A minimal SUMO E3 ligase domain and Smad4-binding domain were defined on PIAS1 protein. The RING finger domain of PIAS1 was essential for its E3 ligase function. Although PIAS1 enhanced the Smad4-dependent transcriptional activation of TGF-beta signaling, a mutant lacking the RING domain inhibited the sumoylation of Smad4 in a dominant negative manner and, as a result, abolished the transcriptional response of TGF-beta. These data demonstrate that PIAS1 protein positively modulates TGF-beta responses as a SUMO E3 ligase for Smad4.
引用
收藏
页码:22857 / 22865
页数:9
相关论文
共 47 条
  • [11] Fuchs SY, 2002, CANCER BIOL THER, V1, P337
  • [12] Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity
    Gill, G
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (02) : 108 - 113
  • [13] Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
    Gross, M
    Liu, B
    Tan, JA
    French, FS
    Carey, M
    Shuai, K
    [J]. ONCOGENE, 2001, 20 (29) : 3880 - 3887
  • [14] SP-RING for SUMO: New functions bloom for a ubiquitin-like protein
    Hochstrasser, M
    [J]. CELL, 2001, 107 (01) : 5 - 8
  • [15] Regulation of transforming growth factor-β signaling by protein inhibitor of activated STAT, PIASy through Smad3
    Imoto, S
    Sugiyama, K
    Muromoto, R
    Sato, N
    Yamamoto, T
    Matsuda, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) : 34253 - 34258
  • [16] A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases
    Jackson, PK
    [J]. GENES & DEVELOPMENT, 2001, 15 (23) : 3053 - 3058
  • [17] The polycomb protein Pc2 is a SUMO E3
    Kagey, MH
    Melhuish, TA
    Wotton, D
    [J]. CELL, 2003, 113 (01) : 127 - 137
  • [18] Involvement of PIAS1 in the sumoylation of tumor suppressor p53
    Kahyo, T
    Nishida, T
    Yasuda, H
    [J]. MOLECULAR CELL, 2001, 8 (03) : 713 - 718
  • [19] Identification of three major sentrinization sites in PML
    Kamitani, T
    Kito, K
    Nguyen, HP
    Wada, H
    Fukuda-Kamitani, T
    Yeh, ETH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) : 26675 - 26682
  • [20] ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation
    Kotaja, N
    Aittomäki, S
    Silvennoinen, O
    Palvimo, JJ
    Jänne, OA
    [J]. MOLECULAR ENDOCRINOLOGY, 2000, 14 (12) : 1986 - 2000